Suppr超能文献

阳性手术切缘可能不影响肾细胞癌患者行部分肾切除术后的生存率:一项基于39项研究的荟萃分析。

Positive surgical margins may not affect the survival of patients with renal cell carcinoma after partial nephrectomy: A meta-analysis based on 39 studies.

作者信息

Bai Renran, Gao Liang, Wang Jiawu, Jiang Qing

机构信息

Department of Nephrology, Qianjiang Central Hospital, Chongqing, China.

Department of Urology, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.

出版信息

Front Oncol. 2022 Aug 10;12:945166. doi: 10.3389/fonc.2022.945166. eCollection 2022.

Abstract

BACKGROUND

So far, whether positive surgical margin(PSM) has adverse effects on the prognosis of patients is still controversial, so we designed this study to systematically evaluate the effect of PSM on the prognosis of patients with renal cell carcinoma (RCC) after partial nephrectomy (PN).

METHODS

On the basis of three electronic databases (PubMed, Embase and the Cochrane Library) up to May 2022, all case-control studies (CCSs) comparing the effects of PSM and negative surgical margin (NSM) after PN on the oncological results of RCC patients were included. Two evaluators independently conducted a systematic literature search and extracted the data we needed. The methodological quality of all studies was evaluated by the modified Newcastle-Ottawa scale. The odds ratio (OR) was used to describe the results for dichotomous variables, and the meta-analysis was conducted using Cochrane Review Manager 5.2 and Stata 14.2.

RESULTS

A total of 39 studies involving 21461 patients were included in our meta-analysis. The pooled results showed that the rates of tumor recurrence (OR 3.93, 95% CI 2.95-5.24; p < 0.00001) and metastasis (OR 4.63, 95% CI 3.11-6.88; p < 0.00001) in the PSM group were significantly higher than those in the NSM group. However, there were no significant differences in the rates of all-cause death (OR 1.35, 95% CI 0.92-1.99; p = 0.13) or cancer-specific death (OR 0.99, 95% CI 0.51-1.94; p = 0.99) between the two groups. In addition, subgroup analyses were carried out according to different average follow-ups, which revealed similar results.

CONCLUSION

Insignificant differences in survival between the PSM and NSM groups were observed, although significant differences in recurrence and metastasis in the PSM group were reported. Our study supported that close monitoring might be another effective choice for patients with PSM after PN. Considering the possible limitations, we recommended cautious interpretation of our results.

摘要

背景

迄今为止,手术切缘阳性(PSM)是否会对患者预后产生不良影响仍存在争议,因此我们设计了本研究,以系统评估PSM对接受肾部分切除术(PN)的肾细胞癌(RCC)患者预后的影响。

方法

基于截至2022年5月的三个电子数据库(PubMed、Embase和Cochrane图书馆),纳入了所有比较PN术后PSM和手术切缘阴性(NSM)对RCC患者肿瘤学结局影响的病例对照研究(CCS)。两名评估者独立进行系统的文献检索并提取我们所需的数据。所有研究的方法学质量通过改良的纽卡斯尔-渥太华量表进行评估。比值比(OR)用于描述二分变量的结果,并使用Cochrane Review Manager 5.2和Stata 14.2进行荟萃分析。

结果

我们的荟萃分析共纳入了39项研究,涉及21461例患者。汇总结果显示,PSM组的肿瘤复发率(OR 3.93,95% CI 2.95 - 5.24;p < 0.00001)和转移率(OR 4.63,95% CI 3.11 - 6.88;p < 0.00001)显著高于NSM组。然而,两组之间的全因死亡率(OR 1.35,95% CI 0.92 - 1.99;p = 0.13)或癌症特异性死亡率(OR 0.99,95% CI 0.51 - 1.94;p = 0.99)没有显著差异。此外,根据不同的平均随访时间进行了亚组分析,结果相似。

结论

尽管报告了PSM组在复发和转移方面存在显著差异,但PSM组和NSM组在生存方面未观察到显著差异。我们的研究支持密切监测可能是PN术后PSM患者的另一种有效选择。考虑到可能存在的局限性,我们建议谨慎解读我们的结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3a2/9399599/0a1929b33b86/fonc-12-945166-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验